A couple of links of note from Publishers Weekly:

The annual Critics Poll results have been announced and to the shock of no one Emil Ferris’s ‘My Favorite Thing Is Monsters’ was #1. We’ve written and talked and been amazed by this book all year and it shows just how far the graphic novel business has come.

201712220250.jpg

The #2 book was Gabrielle Bell’s Everything is Flammable, a little bit more of a surprise but wonderful to see. I think it’s Bell’s best book yet and she was already pretty great.

- Advertisement-

10 of the top 12 books were by women cartoonists. Really, it’s getting to be that you wonder why there are no great male cartoonists.

There are dozens of books of note listed in the honorable mentions – please check out the link and remember that 2017 had some pretty darn good comics.

…as will 2018! Just as a teaser, here’s the cover for My Favorite Thing is Monsters Part 2, coming in August!

617dtWkFJ4L.jpg

Holy hannah!

Earlier this month PW ran their Spring Announcements (collated by…me) with 50 of the graphic novels to look forward to in 2018.  The list includes a top ten, as follows:

All the Answers
Michael Kupperman. S&S/Gallery 13, May 15

Come Again
Nate Powell. IDW/Top Shelf, July 1

The Comic Book Story of Baseball: The Heroes, Hustlers, and History-Making Swings (and Misses) of America’s National Pastime
Alex Irvine, Tomm Coker, and C.P. Smith. Ten Speed, May 8

Fab 4 Mania
Carol Tyler. Fantagraphics, June 26

Gumballs
Erin Nations. IDW/Top Shelf, June 1

Homestuck, Book 1: Act 1 & Act 2
Andrew Hussie. Viz Media, Apr. 13

Is This Guy for Real? The Unbelievable Andy Kaufman
Box Brown. First Second, Feb. 6

Manfried the Man
Caitlin Major and Kelly Bastow. Quirk, May 1

Sabrina
Nick Drnaso. Drawn & Quarterly, May 22

Young Frances
Hartley Lin. AdHouse, May 1

(The reason MFTIM Vol 2 isn’ton the list is it only covers books through July. )

We’ll be covering these books and many more on The Beat in 2018 (and so will PW, of course) so yuo have a lot to look forward to in 2018.

1 COMMENT

Comments are closed.